 | • レポートコード：GIR-2104Z00338 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アダリムマブバイオシミラーのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アダリムマブバイオシミラーの種類別市場規模（錠剤、経口液剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アダリムマブバイオシミラーの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Valeo、Continental、Magna International、Hitachi Automotive、Fujitsu、Ficosa ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：錠剤、経口液剤 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・アダリムマブバイオシミラーの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アダリムマブバイオシミラーのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アダリムマブバイオシミラーのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アダリムマブバイオシミラーの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アダリムマブバイオシミラーの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Adalimumab Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Adalimumab Biosimilar size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Adalimumab Biosimilar market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Adalimumab Biosimilar market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablet
Oral Solution
Market segment by Application can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
The key market players for global Adalimumab Biosimilar market are listed below:
AET BioTech
Amgen
Boehringer Ingelheim
Coherus Biosciences
Fujifilm Kyowa Kirin Biologics
LG Life Sciences/Mochida Pharmaceutical
Momenta Pharmaceuticals
Oncobiologics
Pfizer
Samsung Bioepsis
Sandoz
Zydus Cadila
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Adalimumab Biosimilar Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Adalimumab Biosimilar Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Tablet
1.2.3 Oral Solution
1.3 Market Analysis by Application
1.3.1 Overview: Global Adalimumab Biosimilar Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Adalimumab Biosimilar Market Size & Forecast
1.4.1 Global Adalimumab Biosimilar Sales in Value (2016-2026))
1.4.2 Global Adalimumab Biosimilar Sales in Volume (2016-2026)
1.4.3 Global Adalimumab Biosimilar Price by Type (2016-2026) & (USD/MT)
1.5 Global Adalimumab Biosimilar Production Capacity Analysis
1.5.1 Global Adalimumab Biosimilar Total Production Capacity (2016-2026)
1.5.2 Global Adalimumab Biosimilar Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Adalimumab Biosimilar Market Drivers
1.6.2 Adalimumab Biosimilar Market Restraints
1.6.3 Adalimumab Biosimilar Trends Analysis
2 Manufacturers Profiles
2.1 AET BioTech
2.1.1 AET BioTech Details
2.1.2 AET BioTech Major Business
2.1.3 AET BioTech Adalimumab Biosimilar Product and Services
2.1.4 AET BioTech Adalimumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Adalimumab Biosimilar Product and Services
2.2.4 Amgen Adalimumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Adalimumab Biosimilar Product and Services
2.3.4 Boehringer Ingelheim Adalimumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Coherus Biosciences
2.4.1 Coherus Biosciences Details
2.4.2 Coherus Biosciences Major Business
2.4.3 Coherus Biosciences Adalimumab Biosimilar Product and Services
2.4.4 Coherus Biosciences Adalimumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Fujifilm Kyowa Kirin Biologics
2.5.1 Fujifilm Kyowa Kirin Biologics Details
2.5.2 Fujifilm Kyowa Kirin Biologics Major Business
2.5.3 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Product and Services
2.5.4 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 LG Life Sciences/Mochida Pharmaceutical
2.6.1 LG Life Sciences/Mochida Pharmaceutical Details
2.6.2 LG Life Sciences/Mochida Pharmaceutical Major Business
2.6.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Product and Services
2.6.4 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Momenta Pharmaceuticals
2.7.1 Momenta Pharmaceuticals Details
2.7.2 Momenta Pharmaceuticals Major Business
2.7.3 Momenta Pharmaceuticals Adalimumab Biosimilar Product and Services
2.7.4 Momenta Pharmaceuticals Adalimumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Oncobiologics
2.8.1 Oncobiologics Details
2.8.2 Oncobiologics Major Business
2.8.3 Oncobiologics Adalimumab Biosimilar Product and Services
2.8.4 Oncobiologics Adalimumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Adalimumab Biosimilar Product and Services
2.9.4 Pfizer Adalimumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Samsung Bioepsis
2.10.1 Samsung Bioepsis Details
2.10.2 Samsung Bioepsis Major Business
2.10.3 Samsung Bioepsis Adalimumab Biosimilar Product and Services
2.10.4 Samsung Bioepsis Adalimumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Sandoz
2.11.1 Sandoz Details
2.11.2 Sandoz Major Business
2.11.3 Sandoz Adalimumab Biosimilar Product and Services
2.11.4 Sandoz Adalimumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Zydus Cadila
2.12.1 Zydus Cadila Details
2.12.2 Zydus Cadila Major Business
2.12.3 Zydus Cadila Adalimumab Biosimilar Product and Services
2.12.4 Zydus Cadila Adalimumab Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Adalimumab Biosimilar Sales by Manufacturer
3.1 Global Adalimumab Biosimilar Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Adalimumab Biosimilar Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Adalimumab Biosimilar
3.4 Market Concentration Rate
3.4.1 Top 3 Adalimumab Biosimilar Manufacturer Market Share
3.4.2 Top 6 Adalimumab Biosimilar Manufacturer Market Share
3.5 Global Adalimumab Biosimilar Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Adalimumab Biosimilar Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Adalimumab Biosimilar Market Size by Region
4.1.1 Global Adalimumab Biosimilar Sales in Volume by Region (2016-2026)
4.1.2 Global Adalimumab Biosimilar Revenue by Region (2016-2026)
4.2 North America Adalimumab Biosimilar Revenue (2016-2026)
4.3 Europe Adalimumab Biosimilar Revenue (2016-2026)
4.4 Asia-Pacific Adalimumab Biosimilar Revenue (2016-2026)
4.5 South America Adalimumab Biosimilar Revenue (2016-2026)
4.6 Middle East and Africa Adalimumab Biosimilar Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Adalimumab Biosimilar Sales in Volume by Type (2016-2026)
5.2 Global Adalimumab Biosimilar Revenue by Type (2016-2026)
5.3 Global Adalimumab Biosimilar Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Adalimumab Biosimilar Sales in Volume by Application (2016-2026)
6.2 Global Adalimumab Biosimilar Revenue by Application (2016-2026)
6.3 Global Adalimumab Biosimilar Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Adalimumab Biosimilar Sales by Type (2016-2026)
7.2 North America Adalimumab Biosimilar Sales by Application (2016-2026)
7.3 North America Adalimumab Biosimilar Market Size by Country
7.3.1 North America Adalimumab Biosimilar Sales in Volume by Country (2016-2026)
7.3.2 North America Adalimumab Biosimilar Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Adalimumab Biosimilar Sales by Type (2016-2026)
8.2 Europe Adalimumab Biosimilar Sales by Application (2016-2026)
8.3 Europe Adalimumab Biosimilar Market Size by Country
8.3.1 Europe Adalimumab Biosimilar Sales in Volume by Country (2016-2026)
8.3.2 Europe Adalimumab Biosimilar Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Adalimumab Biosimilar Sales by Type (2016-2026)
9.2 Asia-Pacific Adalimumab Biosimilar Sales by Application (2016-2026)
9.3 Asia-Pacific Adalimumab Biosimilar Market Size by Region
9.3.1 Asia-Pacific Adalimumab Biosimilar Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Adalimumab Biosimilar Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Adalimumab Biosimilar Sales by Type (2016-2026)
10.2 South America Adalimumab Biosimilar Sales by Application (2016-2026)
10.3 South America Adalimumab Biosimilar Market Size by Country
10.3.1 South America Adalimumab Biosimilar Sales in Volume by Country (2016-2026)
10.3.2 South America Adalimumab Biosimilar Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Adalimumab Biosimilar Sales by Type (2016-2026)
11.2 Middle East & Africa Adalimumab Biosimilar Sales by Application (2016-2026)
11.3 Middle East & Africa Adalimumab Biosimilar Market Size by Country
11.3.1 Middle East & Africa Adalimumab Biosimilar Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Adalimumab Biosimilar Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Adalimumab Biosimilar Typical Distributors
12.3 Adalimumab Biosimilar Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Adalimumab Biosimilar Revenue by Type, (USD Million), 2021-2026
Table 2. Global Adalimumab Biosimilar Revenue by Application, (USD Million), 2021-2026
Table 3. AET BioTech Basic Information, Manufacturing Base and Competitors
Table 4. AET BioTech Major Business
Table 5. AET BioTech Adalimumab Biosimilar Product and Services
Table 6. AET BioTech Adalimumab Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Major Business
Table 9. Amgen Adalimumab Biosimilar Product and Services
Table 10. Amgen Adalimumab Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 12. Boehringer Ingelheim Major Business
Table 13. Boehringer Ingelheim Adalimumab Biosimilar Product and Services
Table 14. Boehringer Ingelheim Adalimumab Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Coherus Biosciences Basic Information, Manufacturing Base and Competitors
Table 16. Coherus Biosciences Major Business
Table 17. Coherus Biosciences Adalimumab Biosimilar Product and Services
Table 18. Coherus Biosciences Adalimumab Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Fujifilm Kyowa Kirin Biologics Basic Information, Manufacturing Base and Competitors
Table 20. Fujifilm Kyowa Kirin Biologics Major Business
Table 21. Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Product and Services
Table 22. Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. LG Life Sciences/Mochida Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. LG Life Sciences/Mochida Pharmaceutical Major Business
Table 25. LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Product and Services
Table 26. LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Momenta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Momenta Pharmaceuticals Major Business
Table 29. Momenta Pharmaceuticals Adalimumab Biosimilar Product and Services
Table 30. Momenta Pharmaceuticals Adalimumab Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Oncobiologics Basic Information, Manufacturing Base and Competitors
Table 32. Oncobiologics Major Business
Table 33. Oncobiologics Adalimumab Biosimilar Product and Services
Table 34. Oncobiologics Adalimumab Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Pfizer Basic Information, Manufacturing Base and Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer Adalimumab Biosimilar Product and Services
Table 38. Pfizer Adalimumab Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Samsung Bioepsis Basic Information, Manufacturing Base and Competitors
Table 40. Samsung Bioepsis Major Business
Table 41. Samsung Bioepsis Adalimumab Biosimilar Product and Services
Table 42. Samsung Bioepsis Adalimumab Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Sandoz Basic Information, Manufacturing Base and Competitors
Table 44. Sandoz Major Business
Table 45. Sandoz Adalimumab Biosimilar Product and Services
Table 46. Sandoz Adalimumab Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 48. Zydus Cadila Major Business
Table 49. Zydus Cadila Adalimumab Biosimilar Product and Services
Table 50. Zydus Cadila Adalimumab Biosimilar Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Adalimumab Biosimilar Sales by Manufacturer (2019-2021e) & (K MT)
Table 52. Global Adalimumab Biosimilar Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Adalimumab Biosimilar, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Adalimumab Biosimilar Production Capacity by Company, (K MT): 2020 VS 2021
Table 55. Head Office and Adalimumab Biosimilar Production Site of Key Manufacturer
Table 56. Global Adalimumab Biosimilar Sales by Region (2016-2021e) & (K MT)
Table 57. Global Adalimumab Biosimilar Sales by Region (2021-2026) & (K MT)
Table 58. Global Adalimumab Biosimilar Revenue by Region (2016-2021e) & (USD Million)
Table 59. Global Adalimumab Biosimilar Revenue by Region (2021-2026) & (USD Million)
Table 60. Global Adalimumab Biosimilar Sales by Type (2016-2021e) & (K MT)
Table 61. Global Adalimumab Biosimilar Sales by Type (2021-2026) & (K MT)
Table 62. Global Adalimumab Biosimilar Revenue by Type (2016-2021e) & (USD Million)
Table 63. Global Adalimumab Biosimilar Revenue by Type (2021-2026) & (USD Million)
Table 64. Global Adalimumab Biosimilar Price by Type (2016-2021e) & (USD/MT)
Table 65. Global Adalimumab Biosimilar Price by Type (2021-2026) & (USD/MT)
Table 66. Global Adalimumab Biosimilar Sales by Application (2016-2021e) & (K MT)
Table 67. Global Adalimumab Biosimilar Sales by Application (2021-2026) & (K MT)
Table 68. Global Adalimumab Biosimilar Revenue by Application (2016-2021e) & (USD Million)
Table 69. Global Adalimumab Biosimilar Revenue by Application (2021-2026) & (USD Million)
Table 70. Global Adalimumab Biosimilar Price by Application (2016-2021e) & (USD/MT)
Table 71. Global Adalimumab Biosimilar Price by Application (2021-2026) & (USD/MT)
Table 72. North America Adalimumab Biosimilar Sales by Country (2016-2021e) & (K MT)
Table 73. North America Adalimumab Biosimilar Sales by Country (2021-2026) & (K MT)
Table 74. North America Adalimumab Biosimilar Revenue by Country (2016-2021e) & (USD Million)
Table 75. North America Adalimumab Biosimilar Revenue by Country (2021-2026) & (USD Million)
Table 76. North America Adalimumab Biosimilar Sales by Type (2016-2021e) & (K MT)
Table 77. North America Adalimumab Biosimilar Sales by Type (2021-2026) & (K MT)
Table 78. North America Adalimumab Biosimilar Sales by Application (2016-2021e) & (K MT)
Table 79. North America Adalimumab Biosimilar Sales by Application (2021-2026) & (K MT)
Table 80. Europe Adalimumab Biosimilar Sales by Country (2016-2021e) & (K MT)
Table 81. Europe Adalimumab Biosimilar Sales by Country (2021-2026) & (K MT)
Table 82. Europe Adalimumab Biosimilar Revenue by Country (2016-2021e) & (USD Million)
Table 83. Europe Adalimumab Biosimilar Revenue by Country (2021-2026) & (USD Million)
Table 84. Europe Adalimumab Biosimilar Sales by Type (2016-2021e) & (K MT)
Table 85. Europe Adalimumab Biosimilar Sales by Type (2021-2026) & (K MT)
Table 86. Europe Adalimumab Biosimilar Sales by Application (2016-2021e) & (K MT)
Table 87. Europe Adalimumab Biosimilar Sales by Application (2021-2026) & (K MT)
Table 88. Asia-Pacific Adalimumab Biosimilar Sales by Region (2016-2021e) & (K MT)
Table 89. Asia-Pacific Adalimumab Biosimilar Sales by Region (2021-2026) & (K MT)
Table 90. Asia-Pacific Adalimumab Biosimilar Revenue by Region (2016-2021e) & (USD Million)
Table 91. Asia-Pacific Adalimumab Biosimilar Revenue by Region (2021-2026) & (USD Million)
Table 92. Asia-Pacific Adalimumab Biosimilar Sales by Type (2016-2021e) & (K MT)
Table 93. Asia-Pacific Adalimumab Biosimilar Sales by Type (2021-2026) & (K MT)
Table 94. Asia-Pacific Adalimumab Biosimilar Sales by Application (2016-2021e) & (K MT)
Table 95. Asia-Pacific Adalimumab Biosimilar Sales by Application (2021-2026) & (K MT)
Table 96. South America Adalimumab Biosimilar Sales by Country (2016-2021e) & (K MT)
Table 97. South America Adalimumab Biosimilar Sales by Country (2021-2026) & (K MT)
Table 98. South America Adalimumab Biosimilar Revenue by Country (2016-2021e) & (USD Million)
Table 99. South America Adalimumab Biosimilar Revenue by Country (2021-2026) & (USD Million)
Table 100. South America Adalimumab Biosimilar Sales by Type (2016-2021e) & (K MT)
Table 101. South America Adalimumab Biosimilar Sales by Type (2021-2026) & (K MT)
Table 102. South America Adalimumab Biosimilar Sales by Application (2016-2021e) & (K MT)
Table 103. South America Adalimumab Biosimilar Sales by Application (2021-2026) & (K MT)
Table 104. Middle East & Africa Adalimumab Biosimilar Sales by Country (2016-2021e) & (K MT)
Table 105. Middle East & Africa Adalimumab Biosimilar Sales by Country (2021-2026) & (K MT)
Table 106. Middle East & Africa Adalimumab Biosimilar Revenue by Country (2016-2021e) & (USD Million)
Table 107. Middle East & Africa Adalimumab Biosimilar Revenue by Country (2021-2026) & (USD Million)
Table 108. Middle East & Africa Adalimumab Biosimilar Sales by Type (2016-2021e) & (K MT)
Table 109. Middle East & Africa Adalimumab Biosimilar Sales by Type (2021-2026) & (K MT)
Table 110. Middle East & Africa Adalimumab Biosimilar Sales by Application (2016-2021e) & (K MT)
Table 111. Middle East & Africa Adalimumab Biosimilar Sales by Application (2021-2026) & (K MT)
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Adalimumab Biosimilar Typical Distributors
Table 115. Adalimumab Biosimilar Typical Customers
List of Figures
Figure 1. Adalimumab Biosimilar Picture
Figure 2. Global Adalimumab Biosimilar Sales Market Share by Type in 2020
Figure 3. Tablet
Figure 4. Oral Solution
Figure 5. Global Adalimumab Biosimilar Sales Market Share by Application in 2020
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. Online Pharmacy
Figure 9. Global Adalimumab Biosimilar Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 10. Global Adalimumab Biosimilar Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Adalimumab Biosimilar Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Adalimumab Biosimilar Sales (2016-2026) & (K MT)
Figure 31. Global Adalimumab Biosimilar Production Capacity (2016-2026) & (K MT)
Figure 32. Global Adalimumab Biosimilar Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Adalimumab Biosimilar Market Drivers
Figure 34. Adalimumab Biosimilar Market Restraints
Figure 35. Adalimumab Biosimilar Market Trends
Figure 36. Global Adalimumab Biosimilar Sales Market Share by Manufacturer in 2020
Figure 37. Global Adalimumab Biosimilar Revenue Market Share by Manufacturer in 2020
Figure 38. Adalimumab Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Adalimumab Biosimilar Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Adalimumab Biosimilar Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Adalimumab Biosimilar Sales Market Share by Region (2016-2026)
Figure 42. Global Adalimumab Biosimilar Revenue Market Share by Region (2016-2026)
Figure 43. North America Adalimumab Biosimilar Revenue (2016-2026) & (USD Million)
Figure 44. Europe Adalimumab Biosimilar Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Adalimumab Biosimilar Revenue (2016-2026) & (USD Million)
Figure 46. South America Adalimumab Biosimilar Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Adalimumab Biosimilar Revenue (2016-2026) & (USD Million)
Figure 48. Global Adalimumab Biosimilar Sales Market Share by Type (2016-2026)
Figure 49. Global Adalimumab Biosimilar Revenue Market Share by Type (2016-2026)
Figure 50. Global Adalimumab Biosimilar Price by Type (2016-2026) & (USD/MT)
Figure 51. Global Adalimumab Biosimilar Sales Market Share by Application (2016-2026)
Figure 52. Global Adalimumab Biosimilar Revenue Market Share by Application (2016-2026)
Figure 53. Global Adalimumab Biosimilar Price by Application (2016-2026) & (USD/MT)
Figure 54. North America Adalimumab Biosimilar Sales Market Share by Country (2016-2026)
Figure 55. North America Adalimumab Biosimilar Revenue Market Share by Country (2016-2026)
Figure 56. North America Adalimumab Biosimilar Sales Market Share by Type (2016-2026)
Figure 57. North America Adalimumab Biosimilar Sales Market Share by Application (2016-2026)
Figure 58. Europe Adalimumab Biosimilar Sales Market Share by Country (2016-2026)
Figure 59. Europe Adalimumab Biosimilar Revenue Market Share by Country (2016-2026)
Figure 60. Europe Adalimumab Biosimilar Sales Market Share by Type (2016-2026)
Figure 61. Europe Adalimumab Biosimilar Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Adalimumab Biosimilar Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Adalimumab Biosimilar Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Adalimumab Biosimilar Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Adalimumab Biosimilar Sales Market Share by Application (2016-2026)
Figure 66. South America Adalimumab Biosimilar Sales Market Share by Country (2016-2026)
Figure 67. South America Adalimumab Biosimilar Revenue Market Share by Country (2016-2026)
Figure 68. South America Adalimumab Biosimilar Sales Market Share by Type (2016-2026)
Figure 69. South America Adalimumab Biosimilar Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Adalimumab Biosimilar Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Adalimumab Biosimilar Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Adalimumab Biosimilar Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Adalimumab Biosimilar Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のインフリキシマブ＆バイオシミラー市場 2021：企業別、地域別、種類・用途別 The Infliximab and Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…- 世界の神経バイオシミラー生物学的製剤市場 2021：企業別、地域別、種類・用途別 The Nerve Biosimilar Biological Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界のバイオシミラー試験・開発サービス市場規模・現状・予測（2021年-2027年） The global biosimilar testing and development services is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified…
- 世界のレミケードバイオシミラー市場 2021：企業別、地域別、種類・用途別 The Remicade Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界のバイオシミラー市場 2021：企業別、地域別、種類・用途別 The Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …